AzTrials
AzTrials

E-cigarette UseNCT07624292

An Online Intervention to Reduce E-cigarette Use and Cigarette Smoking Risk in Adolescents

A study testing Virtual Intervention for Behavioral Empowerment (VIBE) in people with E-cigarette Use and Cigarette Smoking Risk, run by University of Southern California.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a brief digital intervention can reduce e-cigarette use and prevent cigarette smoking initiation in teenagers ages 12-17. The main questions it aims to answer are: Compared to the control condition, does the intervention reduce e-cigarette use frequency in teenagers?… Read more about this study

Who is it for?
Ages 12 to 17 years
Conditions the study is for
E-cigarette Use, Cigarette Smoking Risk
What is being tested?
Virtual Intervention for Behavioral Empowerment (VIBE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
No sites listed yet
Study dates
1 Jul 2026to 30 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • be between the ages of 12 to 17
  • be able to read English
  • be a current resident of California
  • report vaping at least one day per week in the past month
  • report no history of cigarette use at screening and baseline
  • have access to a computer or mobile device with internet access

Who cannot join

  • currently receiving nicotine cessation services

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Denise Tran, Ph.D. contact

17145487785

denise.tran@med.usc.edu

About this study

Official title: An Online Intervention to Reduce E-cigarette Use and Potential for Cigarette Smoking in Adolescents

The goal of this clinical trial is to learn if a brief digital intervention can reduce e-cigarette use and prevent cigarette smoking initiation in teenagers ages 12-17. The main questions it aims to answer are:

  • Compared to the control condition, does the intervention reduce e-cigarette use frequency in teenagers?
  • Compared to the control condition, does the intervention reduce risk to start smoking cigarettes in teenagers? Researchers will compare the digital intervention to see if it leads to greater reductions in e-cigarette use and smoking risk than a waitlist control condition.

Participants will complete 5 brief online surveys across 12 weeks, and some will be selected to do a post-intervention virtual interview. In this interview, participants will be asked to share their opinions about the intervention and identify areas that need refinement.

Being tested
Virtual Intervention for Behavioral Empowerment (VIBE)
Keywords
E-cigarette, Tobacco, Nicotine addiction, mHealth
Medical subject headings
Vaping, Tobacco Use Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Intervention for Behavioral Empowerment (VIBE)Other

    The intervention contains Personalized Normative Feedback (PNF), motivational interviewing (MI), and education about vaping and smoking harms. The program begins with the MI-based portion, which includes exploration of their experienced health and personal consequences of vaping and potential reasons for and motivation for shifting vaping behaviors (e.g., to save money, to be free from addiction). Second, the education portion involves presentation of the actual harms posed by e-cigarettes to clarify any misperceptions of the negative effects of vaping and nicotine exposure in teens. Next, users are presented with the PNF portion. In the PNF portion, participants receive feedback about their perceptions of peer vaping by presenting their typical behavior/attitude alongside their perceptions of others' behavior/attitude alongside the actual norm of the behavior/attitude. Lastly, strategies recommended for nicotine cessation are presented.

Study groups in NCT07624292
Study groupRoleWhat they receive
Digital vaping interventionExperimentalVirtual Intervention for Behavioral Empowerment (VIBE) is a one-time 30-minute online intervention that incorporates Personalized Normative Feedback (PNF) for vaping and smoking, motivational enhancement to encourage healthy behavior change, and vaping and smoking-related harms education. Lastly, strategies recommended for nicotine cessation are presented. This intervention can be completed in one sitting or split into multiple sessions and is delivered via an interactive website.
Receives: Other: Virtual Intervention for Behavioral Empowerment (VIBE)
Waitlist controlNo interventionThose in the control arm will be waitlisted and given the option to access VIBE (the intervention) at the end of study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Days vaped in the past 7 days

    Participants will report the number of days they vaped in the past 7 days.

    Measured: Past 7 day vaping measured at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks post-randomization.

  2. Times vape is picked up per day

    Participants will report the number of times they picked up their device to vape per day in the past 7 days.

    Measured: Past 7 day vaping measured at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks post-randomization.

  3. Smoking Susceptibility

    Smoking susceptibility will be assessed with the 4-item Expanded Susceptibility to Smoking Index, with the following responses: Definitely not, Probably not, Probably yes, and Definitely yes. This is a binary outcome. If a respondent answers "definitely not" to all four questions, they are categorized as not susceptible. Any other response on any item flags the respondent as susceptible.

    Measured: Past 7 day smoking susceptibility measured at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks post-randomization.

Secondary outcomes (7)
  1. Vaping Quit Attempts

    Quit attempts will be measured with questions asking for the number of quit attempts lasting at least 1 day since the last assessment.

    Measured: Vaping quit attempts in the past 7 days assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  2. Vaping Descriptive Normative Perceptions

    Participants will report their beliefs regarding the percentage of teens who vaped, number of days individuals their age vaped, the number of times others their age picked up their vaping device per day in the past 30 days,

    Measured: Vaping normative perceptions assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  3. Vaping Injunctive Normative Perceptions

    Participants will report how much they believe others their age approve (or disapprove) of vaping using a 5-point Likert scale (responses options: Strongly disapprove to Strongly approve).

    Measured: Vaping normative perceptions assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  4. Smoking Descriptive Normative Perceptions

    Participants will report their beliefs about the percentage of teens who have smoked, the number of days others their age smoked in the past 30 days, and the quantity of cigarettes others their age smoked per day in the past 30 days.

    Measured: Smoking normative perceptions assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  5. Smoking Injunctive Normative Perceptions

    Participants will report how much they believe others their age approve (or disapprove) of cigarette smoking using a 5-point Likert scale (responses options: Strongly disapprove to Strongly approve).

    Measured: Smoking normative perceptions assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  6. Quitting vaping self-efficacy

    Self-efficacy will be assessed by 2 adapted items that originally assessed self-efficacy to quit smoking. Participants rate their confidence about quitting vaping "someday" and "in the next 6 months."

    Measured: Self-efficacy in the past 7 days assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

  7. Motivation to Quit Vaping

    Motivation will be assessed by asking participants whether they were seriously thinking about quitting vaping with responses ranging from 1 = No, I am not thinking about quitting to 5 = Yes, I want to quit during the next 30 days.

    Measured: Motivation to quit in the past 7 days assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion30 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07624292
Sponsor's protocol ID
T35IP9813
Status last verified
May 2026
First submitted
21 May 2026
Last updated
3 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this study, after de-identification, will be shared. The Study Protocol and Statistical Analysis Plan will also be available. Data will be available beginning 9 months and ending 36 months following article publication to researchers who provide a methodologically sound proposal to achieve the aims in the approved proposal. Proposals must be approved by the Principal Investigator. Please submit requests and usage plans to deniset@usc.edu.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Intervention for Behavioral Empowerment (VIBE) in people with E-cigarette Use and Cigarette Smoking Risk, run by University of Southern California.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Denise Tran, Ph.D. (17145487785, denise.tran@med.usc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Days vaped in the past 7 days (time frame: Past 7 day vaping measured at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks post-randomization.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in